TORONTO, Oct 07, 2008 (BUSINESS WIRE) -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the
Company will present at the Natixis Bleichroeder 2nd
Annual Hidden Gems Conference at The Waldorf=Astoria hotel in New York
City.

Biovail's presentation is scheduled for Monday, October 13, 2008 at 2
p.m. EDT. A live and archived Webcast will be available on the Investor
Relations page of Biovail's Web site at www.biovail.com.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products. The Company is focused on
the development and commercialization of medicines that address unmet
medical needs in niche specialty central nervous system (CNS) markets.
For more information about Biovail, visit the Company's
Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.

SOURCE: Biovail Corporation

Biovail Corporation 
Nelson F. Isabel, (905) 286-3000 
VP, Investor Relations & Corporate Communications

Copyright Business Wire 2008